News
ZoomRx surveyed 57 neurologists in the U.S. this month, revealing that no single drug brand holds more than 5% of top-of-mind ...
MIT researchers have developed a new theoretical framework for studying the mechanisms of treatment interactions. Their ...
Mexico’s government clarified there was “no indication” that an airplane it intercepted loaded with cocaine had originated ...
All bottles of an ulcer medication have been recalled by the remains of a Kansas City drug company that filed Chapter 11 ...
Although Viagra is effective for most guys with erectile dysfunction (ED), it’s important to make sure you’re taking the right dose. Too low of a Viagra dosage and your erections may not be as firm or ...
2d
Calgary Herald on MSNUofC study standardizes medication dosage for children with acute vomiting post ER visitFor emergency doctors figuring out how much medication to discharge a child with after they visit the hospital for acute ...
The country’s Medicines and Healthcare products Regulatory Agency’s Yellow Card scheme, the UK’s official system for ...
The drug is now approved for treating people with an LVEF of at least 40%, with or without chronic kidney disease.
In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally ...
10d
Zacks Investment Research on MSNIs Novo Nordisk Increasing Dosage to Defend Wegovy's Edge in Obesity?Novo Nordisk NVO announced that it has submitted a regulatory application to the European Medicines Agency (EMA) seeking ...
1d
HealthDay on MSNApproved-Label Populations for New Drugs Broader Than Trial PopulationsApproved label populations for new drugs are broader than trial populations overall, according to a recent study.
Treatments for bronchiectasis, chronic immune thrombocytopenia, fibromyalgia, Friedreich ataxia, and recurrent respiratory papillomatosis are under review.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results